Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratect for chronic idiopathic pain syndromes
2005-004918-32Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of IgPro10 in fibromyalgia (FM), chronic myofascial pain (CMP), complex regional pain syndrome (CRPS) and 1 more, sponsored by Biotest AG. Primary endpoint: Mean pain level reduction at day 14. Started Jan 2006; status: completed.
02
Drugs
IgPro10
03
Conditions
fibromyalgia (FM)chronic myofascial pain (CMP)complex regional pain syndrome (CRPS)chronic idiopathic pain syndrome
Beyond the preview
Go deeper on 2005-004918-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004918-32.